Skip to content
10-Q

Quarterly Report

Entia Biosciences, Inc.

0001185185-16-004588

← back to feed
Filed
May 16, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 16, 2016 28.14M sh
Operating Cash Flow Q1 2016 · Mar 31, 2016 −$99.19K
Operating Cash Flow Q1 2016 · Mar 31, 2015 $14.12K
Cash And Equivalents Q1 2016 · Mar 31, 2016 $0
Cash And Equivalents Q1 2016 · Dec 31, 2015 $24.13K
Cash And Equivalents Q1 2016 · Mar 31, 2015 $179.15K
Cash And Equivalents Q1 2016 · Dec 31, 2014 $99.46K
Stockholders Equity Q1 2016 · Mar 31, 2016 −$1.03M
Stockholders Equity Q1 2016 · Dec 31, 2015 −$791.19K
Current Liabilities Q1 2016 · Mar 31, 2016 $1.28M
Current Liabilities Q1 2016 · Dec 31, 2015 $1.24M
Total Liabilities Q1 2016 · Mar 31, 2016 $1.43M
Total Liabilities Q1 2016 · Dec 31, 2015 $1.24M
Current Assets Q1 2016 · Mar 31, 2016 $85.71K
Current Assets Q1 2016 · Dec 31, 2015 $128.34K
Total Assets Q1 2016 · Mar 31, 2016 $405.77K
Total Assets Q1 2016 · Dec 31, 2015 $448.61K
Sga Expense Q1 2016 · Mar 31, 2016 $243.85K
Sga Expense Q1 2016 · Mar 31, 2015 $380.66K
Net Income Q1 2016 · Mar 31, 2016 −$272.59K
Net Income Q1 2016 · Mar 31, 2015 −$520.51K
Operating Income Q1 2016 · Mar 31, 2016 −$269.91K
Operating Income Q1 2016 · Mar 31, 2015 −$460.81K
Gross Profit Q1 2016 · Mar 31, 2016 $46.84K
Gross Profit Q1 2016 · Mar 31, 2015 $70.7K
Cost Of Revenue Q1 2016 · Mar 31, 2016 $32.36K
Cost Of Revenue Q1 2016 · Mar 31, 2015 $31.63K
Revenue Q1 2016 · Mar 31, 2016 $79.2K
Revenue Q1 2016 · Mar 31, 2015 $102.33K